Financials
Financial year 2025
NP PHARMA from Mons, company number BE1019981328, closed financial year 2025 with a result of € 37,694 after tax. For that financial year NP PHARMA recorded a gross margin of € 51,489 and equity of € 40,694. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 4, 2026.
€ 40,694
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 37,694
Profit after tax over the fiscal year.
€ 54,332
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 37,694.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 757
Supplier invoices still open on the last day of the fiscal year.
€ 19,714
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to NP PHARMA?
What happened at NP PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 37,694. Source: NBB ↗
- New establishment in Mons. KBO
- Nicolas Pizzoferrato became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 13,112 in corporate taxes since 2025.
A new publication or filing at NP PHARMA? We notify you, reason included.
Follow NP PHARMADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind NP PHARMA is Nicolas Pizzoferrato.
Directors
According to the 2025 annual accounts
Nicolas Pizzoferrato
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Résidence du Rieu 8
7030 Mons
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1019.981.328
- VAT number
- BE 1019.981.328
- Registered office
- Résidence du Rieu 8, 7030 Mons
- Names & denominations
- NP PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 February 2025
- Peppol
- Active · Active since 3 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Activiteiten van toeristische informatiediensten